Skip to content
IDIBELL
  • Donate!
  • Contact
  • Intranet
  • En
    • Ca
    • Es
Below Header
  • The Institute
  • Research
  • Services
  • Innovation
  • News & Events
  • Scientific culture
  • Home
  • Neuroscience Area
  • Neuroscience Program
  • Neuropharmacology and pain 

Neuropharmacology and pain 

08/05/2025

The first device capable of activating a light-activated drug by remote control has been designed

03/02/2025

A light-activated drug to fight psoriasis

12/11/2024

Researchers identify a potential biomarker of Parkinson’s disease progression

08/11/2022

Researchers define the molecular mechanism associated with juvenile Parkinson’s

10/02/2022

Convalescent plasma treatment against COVID-19 is not effective

30/12/2021

We close a 2021 full of science!

09/09/2021

Light-activated drugs, localized medicine without side effects

25/03/2021

Possible new biomarker for Parkinson’s disease

27/10/2020

The lack of interaction between two neuronal receptors is a determining factor in schizophrenia

22/04/2020

“The research will bring us the knowledge to be able to attack the pandemic” Sebastià Videla

  • 1
  • 2
  • 3
  • Next »

Direct links

  • Comittees and boards
  • Transparency
  • Complaints channel
  • Channel against discrimination and harassment
  • Legal notice
  • Privacy Policy
  • Privacy policy social networks

Follow us

  • 𝕏
  • Facebook
  • Youtube
  • Linkedin
  • Instagram

Contact

+34 93 607 38 00
info@idibell.cat

Localization

Hospital Duran i Reynals
2a planta Edifici Terapèutic
Av. Granvia de l’Hospitalet, 199
08908 L’Hospitalet de Llobregat (Barcelona)

IDIBELL
Copyright © 2025 Institut d’Investigació Biomèdica de Bellvitge
Manage Cookie Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Funcional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Manage options Manage services Manage {vendor_count} vendors Read more about these purposes
View preferences
{title} {title} {title}
Scroll to Top